Survivin, a Promising Gene for Targeted Cancer Treatment

作者: Nasibeh Daneshvar , Parvaneh Mehrbod , Fatemeh T Shamsabadi , Majid Shahbazi , Ahad Yamchi

DOI:

关键词:

摘要: Drawbacks of conventional cancer treatments, with lack specificity and cytotoxicity using current approaches, underlies the necessity for development a novel approach, gene-directed therapy. This has provided technological opportunities in vitro vivo. review focuses on member an apoptosis inhibitor family, survivin, as valuable target. Not only gene but also its promoter are applicable this context. article is based literature survey, especial attention to RNA interference well tumor- specific action. The search engine databases utilized were Science direct, PubMed, MEDLINE Google. In addition cell-cycle modulation, inhibition, interaction cell-signaling pathways, cancer-selective expression, survivin may be considered target through treatment cancer. Our purpose writing was create awareness researchers, emphasizing relation expression potential treatment. principal result major conclusion manuscript that structure, biological functions applications systems tumor-specific activity interest

参考文章(91)
Yun Fan, Andreas Bergmann, Apoptosis-induced compensatory proliferation. The Cell is dead. Long live the Cell! Trends in Cell Biology. ,vol. 18, pp. 467- 473 ,(2008) , 10.1016/J.TCB.2008.08.001
Ilya V. Ulasov, Zeng B. Zhu, Matthew A. Tyler, Yu Han, Angel A. Rivera, Andrey Khramtsov, David T. Curiel, Maciej S. Lesniak, Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma. Human Gene Therapy. ,vol. 18, pp. 589- 602 ,(2007) , 10.1089/HUM.2007.002
T Kaufmann, A Strasser, P J Jost, Fas death receptor signalling: roles of Bid and XIAP Cell Death & Differentiation. ,vol. 19, pp. 42- 50 ,(2012) , 10.1038/CDD.2011.121
Zeng B. Zhu, Sharmila K. Makhija, Baogen Lu, Minghui Wang, Shuyi Wang, Koichi Takayama, Gene P. Siegal, Paul N. Reynolds, David T. Curiel, Targeting Mesothelioma Using an Infectivity Enhanced Survivin-Conditionally Replicative Adenoviruses Journal of Thoracic Oncology. ,vol. 1, pp. 701- 711 ,(2006) , 10.1016/S1556-0864(15)30385-3
Armando van der Horst, Susanne M.A. Lens, Cell division: control of the chromosomal passenger complex in time and space Chromosoma. ,vol. 123, pp. 25- 42 ,(2014) , 10.1007/S00412-013-0437-6
Matthias Kappler, Helge Taubert, Frank Bartel, Karen BLümke, Matti Panian, Hannelore Schmidt, Jürgen Dunst, Matthias Bache, Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line. Oncology Reports. ,vol. 13, pp. 167- 172 ,(2005) , 10.3892/OR.13.1.167
Ofer Levy, Therapeutic potential of the bactericidal/permeability-increasing protein. Expert Opinion on Investigational Drugs. ,vol. 11, pp. 159- 167 ,(2002) , 10.1517/13543784.11.2.159
D.T. Zhu, Z.B., Makhija, S.K., Lu, B., Wang, M., Rivera, A.A., Kim-Park, S.K., Ulosov, I.V., Zhou, F., Alvarez, R.D., Siegal, G.P., and Curiel, None, Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo International Journal of Oncology. ,vol. 27, pp. 237- 246 ,(2005) , 10.3892/IJO.27.1.237
Byoung Heon Kang, Dario C. Altieri, Jagadish C. Ghosh, Takehiko Dohi, Hsp60 Regulation of Tumor Cell Apoptosis Journal of Biological Chemistry. ,vol. 283, pp. 5188- 5194 ,(2008) , 10.1074/JBC.M705904200
Haifeng Xia, Shaomu Chen, Haitao Huang, Haitao Ma, Survivin over-expression is correlated with a poor prognosis in esophageal cancer patients Clinica Chimica Acta. ,vol. 446, pp. 82- 85 ,(2015) , 10.1016/J.CCA.2015.04.009